The group’s principal activity is to develop both medical devices as well as pharmaceutical agents to be used in important pathologies. In the year 2005 the group acquired OptiMetrix Technologies, Inc. The group operates from the United States. The group’s net sale in the year 2005 was $ 1,087,136.